結果 : checkmate 227 ema approval
5:13

CheckMate-227 Regimen Safety Profile

OncLive
89 回視聴 - 4 年前
6:13

CheckMate-227: Testing Ipilimumab/Nivolumab in NSCLC

OncLive
413 回視聴 - 6 年前
17:08

Three-Year Update From the CheckMate 227 Clinical Trial for Advanced NSCLC

OncLive
838 回視聴 - 4 年前
8:13

Checkmate 816: Combining Chemo and Opdivo - ASCO Lung Review 2022

GRACE - Global Resource for Advancing Cancer Education
655 回視聴 - 2 年前
44:56

Advanced NSCLC: Refining Clinical Pathways in the Rapidly Evolving Therapeutic Landscape

HMP Education
3,985 回視聴 - 3 年前
0:39

Dr. Lopes on the FDA Approval of Nivolumab/Ipilimumab in NSCLC

OncLive
319 回視聴 - 4 年前
6:31

Recent Combination Approval: CheckMate-9LA Regimen

OncLive
159 回視聴 - 4 年前
2:28

Perspectives on the CheckMate 9LA study

VJOncology
208 回視聴 - 4 年前
1:44

CheckMate 649: nivolumab and chemotherapy or ipilimumab in GC/GEJC/EAC

VJOncology
151 回視聴 - 1 年前
6:31

CheckMate 649 biomarker analyses of NIVO + IPI vs chemo for patients with GC/GEJC/EAC

ecancer
93 回視聴 - 1 年前
36:32

Optimizing Immunotherapy Combination Strategies for Metastatic NSCLC: From Evidence to Practice

Medscape
6 回視聴 - 3 か月前
52:25

Nontargeted Treatments for Lung Cancer | Third Annual National General Medical Oncology Summit

Research To Practice
46 回視聴 - 5 か月前
3:59

Checkmate 067 - combined nivolumab and ipilimumab

ecancer
1,323 回視聴 - 7 年前
16:53

Lung ESMO 2022 Highlights - OncBrothers (Rohit and Rahul Gosain) with Dr. Joshua Reuss

OncBrothers: Practice-Changing Cancer Discussions
200 回視聴 - 1 年前
1:04:20

Winship Grand Rounds: January 20, 2021 - Timothy Chan, MD, PhD

Winship Cancer Institute of Emory University
366 回視聴 - 3 年前
1:22:09

Illuminating the Path With Immunotherapy for Metastatic, Locally Advanced, and Early Stage NSCLC

PeerView Oncology
304 回視聴 - 2 か月前
8:21

FDA Approval of a Biosimilar, Priority Review in Epithelioid Sarcoma, and More

OncLive
231 回視聴 - 5 年前
7:47

NIVOLUMAB / IPILIMUMAB APPROVED IN EUROPE FOR FRONTLINE UNRESECTABLE MALIGNANT PLEURAL MESOTHELIOMA

Mesothelioma USA
38 回視聴 - 3 年前
3:14

Expert highlights: RCC immunotherapy at ESMO 2019 | Axel Merseburger

Medicine Matters oncology
170 回視聴 - 4 年前
1:01:06

IASLC Webinar: Perioperative Treatment w/Immune Checkpoint Inhibitors in Patients w/Resectable NSCLC

IASLC
914 回視聴 - 2 年前